Excellent! Hence why SYC is targeting cancers of unmet needs! Its the quickest and least expensive route to commercialisation.
"The benefits of an Orphan Drug Designation are considerable and include guaranteed market exclusivity of seven years from granting of regulatory approval; and a waiver of Prescription Drug User Fee Act (PDUFA) fees for orphan drugs, which has a value of over US$3.1 million in 2021."
- Forums
- ASX - By Stock
- Ann: US FDA Grants Orphan Drug Designation to PTX-100 for PTCL
Excellent! Hence why SYC is targeting cancers of unmet needs!...
-
- There are more pages in this discussion • 58 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PTX (ASX) to my watchlist
(20min delay)
|
|||||
Last
4.3¢ |
Change
-0.001(2.27%) |
Mkt cap ! $34.62M |
Open | High | Low | Value | Volume |
4.3¢ | 4.3¢ | 4.3¢ | $5.18K | 120.4K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 162069 | 4.3¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
4.4¢ | 8200 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 162069 | 0.043 |
4 | 282657 | 0.042 |
6 | 439000 | 0.041 |
9 | 1349510 | 0.040 |
2 | 210000 | 0.039 |
Price($) | Vol. | No. |
---|---|---|
0.044 | 8200 | 1 |
0.045 | 26000 | 1 |
0.048 | 2664 | 1 |
0.049 | 70000 | 1 |
0.051 | 277227 | 2 |
Last trade - 11.03am 21/10/2024 (20 minute delay) ? |
Featured News
PTX (ASX) Chart |
The Watchlist
LGP
LITTLE GREEN PHARMA LTD
Paul Long, Chief Executive Officer
Paul Long
Chief Executive Officer
SPONSORED BY The Market Online